BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1100914)

  • 1. Offsetting toxicity of antineoplastic agents.
    Cook ES; Nutini LG; Fardon JC; Proudfoot MB; Poydock ME
    J Surg Oncol; 1975; 7(5):337-45. PubMed ID: 1100914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I; Venditti JM; Mead JA; Tyrer DD; Goldin A
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a yeast extract (PCO) on the mitotic activity of neoplastic and normal cells in vitro.
    Fardon JC; Poydock ME; Tsuchiya Y
    J Surg Oncol; 1973; 5(4):307-14. PubMed ID: 4583381
    [No Abstract]   [Full Text] [Related]  

  • 4. Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues.
    Straw JA; Talbot DC; Taylor GA; Harrap KR
    J Natl Cancer Inst; 1977 Jan; 58(1):91-7. PubMed ID: 299894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo antitumor activity of hydrosoluble derivatives of 7-hydroxycholesterols].
    Rong S; Bergmann C; Luu B; Beck JP; Ourisson G
    C R Acad Sci III; 1985; 300(3):89-94. PubMed ID: 3919887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy: the interaction of methotrexate and 5-fluorouracil.
    Tattersall MH; Jackson RC; Connors TA; Harrap KR
    Eur J Cancer (1965); 1973 Oct; 9(10):733-9. PubMed ID: 4529730
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of methotrexate on folates in Krebs ascites and L1210 murine leukemia cells.
    Kesavan V; Sur P; Doig MT; Scanlon KJ; Priest DG
    Cancer Lett; 1986 Jan; 30(1):55-9. PubMed ID: 3943080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs.
    Danysz A; Sołtysiak-Pawluczuk D; Czyzewska-Szafran H; Jedrych A; Jastrzebski Z
    Drugs Exp Clin Res; 1991; 17(2):133-8. PubMed ID: 1864228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
    Bruckner HW; Schreiber C; Waxman S
    Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase.
    Quemener V; Quash G; Moulinoux JP; Penlap V; Ripoll H; Havouis R; Doutheau A; Goré J
    In Vivo; 1989; 3(5):325-30. PubMed ID: 2519873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimitotic agents and tumor regression.
    Nutini LG; Fardon JC; Poydock ME
    Oncology; 1974; 30(5):436-41. PubMed ID: 4462062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of massive-dose chemotherapy of malignant disease.
    Bergsagel DE
    Can Med Assoc J; 1971 Jan; 104(1):31-6. PubMed ID: 4322068
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches to cancer chemotherapy with methotrexate.
    Frei E; Jaffe N; Tattersall MH; Pitman S; Parker L
    N Engl J Med; 1975 Apr; 292(16):846-51. PubMed ID: 1078714
    [No Abstract]   [Full Text] [Related]  

  • 17. The interval between methotrexate and leucovorin determines the efficacy of 5-fluorouracil modulation in vitro and in vivo.
    van der Wilt CL; de Jong M; Braakhuis BJ; Pinedo HM; Peters GJ
    Adv Exp Med Biol; 1993; 338():609-12. PubMed ID: 8304191
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential toxicity of carrier-bound methotrexate against tumor/bone marrow cells in vivo.
    Chu BC; Howell SB
    Biochem Pharmacol; 1982 Nov; 31(21):3513-7. PubMed ID: 7150373
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of allopurinol on the therapeutic efficacy of methotrexate.
    Grindey GB; Moran RG
    Cancer Res; 1975 Jul; 35(7):1702-5. PubMed ID: 1131828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.